All Pathways
Vascular SurgeryManagement

Chronic Limb-Threatening Ischemia Management (GVG 2019)

Chronic Limb-Threatening Ischemia Management (GVG 2019): Suspected CLTI → Clinical Diagnosis → Hemodynamic Assessment → PLAN Framework → Revascularizati...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected CLTI

    Rest pain, non-healing ulcer, or gangrene with evidence of PAD

    1. Action

      Clinical Diagnosis

      CLTI = ischemic rest pain or tissue loss + objective evidence of PAD

      • Ischemic rest pain: night pain, hanging leg over bed
      • Tissue loss: non-healing ulcer, gangrene
      • Duration >2 weeks
      • Objective evidence: ABI <0.4, toe pressure <30 mmHg, TcPO2 <30 mmHg
      1. Action

        Hemodynamic Assessment

        Objective ischemia evaluation

        • ABI: <0.4 = severe ischemia
        • Toe-brachial index (TBI): <0.3 = severe
        • Toe pressure: <30 mmHg
        • TcPO2: <30 mmHg
        • Note: ABI may be falsely elevated in diabetics
        1. Decision

          PLAN Framework

          Patient risk, Limb staging, ANatomic pattern

          • P: Patient risk (comorbidities, life expectancy, ambulatory status)
          • L: Limb staging (WIfI stage, functional status)
          • AN: Anatomic pattern (GLASS, target vessel, conduit)
          • Guides treatment intensity
          1. Decision

            Revascularization Beneficial?

            Based on PLAN assessment

            • High benefit: WIfI 2-4, adequate target, reasonable risk
            • Low benefit: limited life expectancy, non-ambulatory, no target
            • Consider primary amputation if patient/limb factors unfavorable
            1. Action

              Endovascular-First Strategy

              Preferred for many patients

              • Lower perioperative risk
              • PTA ± stenting
              • Drug-coated balloons for femoropopliteal
              • Goal: in-line flow to foot
              • May need staged procedures
              1. Action

                Comprehensive Wound Care

                Essential alongside revascularization

                • Debridement of non-viable tissue
                • Offloading (total contact cast, removable boot)
                • Moist wound healing environment
                • Infection control (IV antibiotics if needed)
                • Multidisciplinary limb salvage team
                1. Action

                  Post-Revascularization Surveillance

                  Graft/stent surveillance program

                  • Duplex surveillance: 1, 3, 6, 12 months then annually
                  • Detect stenosis before occlusion
                  • ABI monitoring
                  • Wound healing assessment
                  • Repeat intervention for failing graft/stent
                  1. Outcome

                    Limb Salvage

                    1-year limb salvage 70-80% with revascularization

                  2. Outcome

                    Wound Healing

                    Complete healing in 50-60% at 1 year; tissue loss may require minor amputation

                  3. Outcome

                    Major Amputation

                    20-30% at 1 year despite therapy; mortality 20-30% at 1 year

              2. Action

                Medical Optimization

                Risk factor control essential

                • Antiplatelet therapy (aspirin ± clopidogrel post-intervention)
                • High-intensity statin
                • Diabetes control (HbA1c target individualized)
                • Blood pressure control
                • Smoking cessation (critical)
            2. Action

              Open Surgical Bypass

              Best for suitable anatomy and conduit

              • Single-segment great saphenous vein preferred
              • Femoropopliteal or femorotibial bypass
              • Superior durability vs endovascular for GLASS P2/FP2C/D
              • Requires adequate conduit and target
              • Higher perioperative risk
            3. Action

              Hybrid Approach

              Combined open and endovascular

              • Inflow lesion: endovascular
              • Outflow: surgical bypass
              • Staged or simultaneous
              • Individualized based on anatomy
              • Common: iliac PTA + femoral-popliteal bypass
            4. Warning

              Primary Amputation

              When revascularization not beneficial

              • Extensive gangrene/necrosis beyond salvage
              • Non-ambulatory with fixed flexion contracture
              • Limited life expectancy (comfort focus)
              • No revascularization target
              • Patient preference after informed discussion
      2. Action

        WIfI Staging

        Wound, Ischemia, foot Infection classification

        • W (Wound): 0-3 based on depth, extent, gangrene
        • I (Ischemia): 0-3 based on ABI, ankle/toe pressure
        • fI (foot Infection): 0-3 IDSA/IWGDF criteria
        • Predicts amputation risk and revascularization benefit
      3. Action

        Anatomic Imaging

        Define disease extent for revascularization planning

        • CTA or MRA (preferred non-invasive)
        • Duplex ultrasound (adjunct)
        • Catheter angiography if intervention planned
        • GLASS classification: femoropopliteal + infrapopliteal patterns
        • Assess target vessel for revascularization

Guideline Source

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • CLTI terminology replaced CLI (critical limb ischemia)
  • WIfI staging requires wound assessment expertise
  • GLASS anatomic classification complex - vascular specialist needed
  • Diabetes and renal failure significantly impact outcomes
  • Shared decision-making essential given amputation risk

Applicable Regions

USEUGlobal

EU: GVG 2019 developed jointly by SVS, ESVS, WFVS

US: ACC/AHA 2024 PAD guidelines incorporate CLTI management

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Chronic Limb-Threatening Ischemia Management (GVG 2019)?

The Chronic Limb-Threatening Ischemia Management (GVG 2019) is a management clinical algorithm for Vascular Surgery. It provides a structured decision tree to guide clinical decision-making, based on Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

What guideline is the Chronic Limb-Threatening Ischemia Management (GVG 2019) based on?

This algorithm is based on Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia (DOI: 10.1016/j.ejvs.2019.05.006).

What are the limitations of the Chronic Limb-Threatening Ischemia Management (GVG 2019)?

Known limitations include: CLTI terminology replaced CLI (critical limb ischemia); WIfI staging requires wound assessment expertise; GLASS anatomic classification complex - vascular specialist needed; Diabetes and renal failure significantly impact outcomes; Shared decision-making essential given amputation risk. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Chronic Limb-Threatening Ischemia Management (GVG 2019) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free